ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report) was down 1% during mid-day trading on Wednesday . The company traded as low as $0.95 and last traded at $0.98. Approximately 28,607 shares were traded during mid-day trading, an increase of 41% from the average daily volume of 20,327 shares. The stock had previously closed at $0.99.
ImmunoPrecise Antibodies Stock Up 3.3 %
The stock has a 50 day simple moving average of $1.08 and a 200 day simple moving average of $1.42.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.
Read More
- Five stocks we like better than ImmunoPrecise Antibodies
- What is the S&P/TSX Index?
- Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
- What Are the FAANG Stocks and Are They Good Investments?
- This Financial Stock’s Earnings Signal a Buying Opportunity
- Investing In Preferred Stock vs. Common Stock
- Social Platform Stock Hits New Highs: Is More Growth Ahead?
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.PNG?v=20210211152252&h=45&w=95&zc=2){kind=logo}